Inspire Medical Systems, Inc. · NYSE:INSP

Inspire Medical Systems — Stifel Healthcare Conference 2026

10 slides from Inspire Medical Systems's conference presentation, Nov 10, 2026

  1. Slide 1: Inspire Medical Systems, Inc. Stifel Healthcare Conference 2026

    Inspire Medical Systems, Inc. Stifel Healthcare Conference 2026 November 2026

  2. Slide 2: Disclaimer

    Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward- looking statements, including, without limitation, statements regarding estimated financi

  3. Slide 3: Company overview

    Company overview The first and only… >$10 BILLION Underpenetrated U.S. market >400 PUBLICATIONS Compelling body of evidence Innovative, closed-loop, ~1,300 EMPLOYEES neurostimulation Led by a proven management team technology >300 MILLION U.S. COVERED LIVES for Obstructive Sleep Established reimburs

  4. Slide 4: Inspire Therapy is an Innovative and Proven Solution

    Closed-loop, or Synchronized Stimulation, Inspire Therapy is is delivered when airway is most vulnerable to collapse (inspiratory phase) an Innovative and Proven Solution for Patients with 1 OSA Sensing with Inspire V is SUPERIOR to Inspire IV 2 Proprietary Closed-Loop Inspire V Sensing Algorithm to

  5. Slide 5: Key catalysts and updates

    Key catalysts and updates 1 2 3 Reimbursement Inspire V & Clinical Data Project Horizon Near term: Improved clarity 5th Gen system: Improved patient Created $30M of incremental regarding coding pathway, and outcomes and physician growth investment capacity: effective customer education experience Ex

  6. Slide 6: Expanding Clinical Evidence Strengthens the Inspire Value Proposition

    Expanding Clinical Evidence Strengthens the Inspire Value Proposition Recent studies expand the evidence supporting patient outcomes, cardiovascular health, and treatment pathway optimization Inspire V Performance Physiologic Disease Cardiovascular & Patient Identification & Impact Systemic Outcomes

  7. Slide 7: 3Q26 Highlights

    3Q26 Highlights1 Results Ahead of Expectations: 3.0% sequential revenue growth with $206.7M strength in U.S. business, coding and reimbursement disruption primary Revenue (7.9%) Y/Y, +3.0% Q/Q driver of Y/Y revenue decline of 7.9% Gross Margin Expansion: Gross margin expansion and disciplined spendi

  8. Slide 8: Project Horizon Enables Incremental Growth Investment Capacity

    Project Horizon Enables Incremental Growth Investment Capacity Optimizing Organizational Structure to Align Resources to Support Revenue Growth $30M Created incremental annualized growth investment capacity; prioritizing investments in patient flow Improving patient Expanding patient Support in navi

  9. Slide 9: Summary

    Summary Enhanced coding clarity in 2026 and 2027, new Category 1 CPT Code in 2028 Inspire V data shows improved patient outcomes and physician experience Recent studies expand the evidence supporting patient outcomes, cardiovascular health, and treatment pathway optimization Project Horizon creates

  10. Slide 10: No mask. No hose. Just sleep.

    No mask. No hose. ® Just sleep. 10 INSPIRE CONFIDENTIAL. Inspire is a public company and has an Insider Trading Policy. The content in this deck is not to be shared with anybody outside of Inspire Medical Systems, Inc. It is for internal review and discussion only www.inspiresleep.com

Inspire Medical Systems — Stifel Healthcare Conference 2026 on 6ix